logo

For the Inventor, By the Inventor

Berlin, Germany

Gerda Mannesmann

USPTO Granted Patents = 12

Average Co-Inventor Count = 6.2

ph-index = 4

Forward Citations = 70(Granted Patents)


Location History:

  • Berlin, DE (1980 - 1987)
  • Cologne, DE (1985 - 1992)

Company Filing History:

goldMedal12 out of 1,384 
 
Schering Aktiengesellschaft
 patents

Years Active: 1980-1992

Loading Chart...
12 patents (USPTO):Explore Patents
1. 5157042 - 3-oxa-5-fluoro-carbacyclins, their preparation and use as medicinal (1992-10-20),
2. 5124343 - Carbacyclins, process for the preparation thereof, and use thereof as (1992-06-23),
3. 4954524 - Carbacylcins, their preparation and use as medicinal agents (1990-09-04),
4. 4692464 - Novel prostacyclin derivatives and a process for the preparation thereof (1987-09-08),
5. 4618626 - Novel carbacyclin esters, process for the preparation thereof, and their (1986-10-21),
6. 4552875 - Novel carbacyclinamides, their preparation and use as medicinal agents (1985-11-12),
7. 4497830 - Carbacyclins, their preparation and pharmacological use (1985-02-05),
8. 4466969 - 7-Oxoprostacyclin derivatives and their use as hypotensives and (1984-08-21),
9. 4378370 - Certain 5-cyano-16-fluoro-prostacyclins and their use as pharmaceuticals (1983-03-29),
10. 4315013 - Certain pyrrole analogs of prostacyclin derivatives (1982-02-09),
11. 4219479 - 5-Cyano-prostacyclin derivatives (1980-08-26),
12. 4191694 - Prostaglandin-I.sub.2 derivatives (1980-03-04),

Title: Gerda Mannesmann: Innovator in Medicinal Chemistry

Introduction

Gerda Mannesmann is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of medicinal chemistry, particularly through her innovative work on carbacyclins. With a total of 12 patents to her name, Mannesmann has established herself as a key figure in her area of expertise.

Latest Patents

Among her latest patents are the development of 3-oxa-5-fluoro-carbacyclins, which are notable for their preparation and medicinal use. These carbacyclin derivatives are characterized by a specific formula where R1 can be OR2, with R2 representing various chemical residues such as hydrogen, alkyl, cycloalkyl, or aryl. Another significant patent involves the process for preparing carbacyclins, which includes a general formula where R1 is the residue CH2OH or other specified residues, showcasing her innovative approach to medicinal compounds.

Career Highlights

Mannesmann's career is marked by her dedication to advancing medicinal chemistry. She has worked extensively on the synthesis and application of carbacyclins, contributing to the development of new therapeutic agents. Her work has not only expanded the understanding of these compounds but has also paved the way for potential medical applications.

Collaborations

Throughout her career, Mannesmann has collaborated with notable colleagues, including Werner Skuballa and Helmut Vorbrueggen. These partnerships have enhanced her research and contributed to the successful development of her patented inventions.

Conclusion

Gerda Mannesmann's contributions to medicinal chemistry through her innovative patents highlight her role as a leading inventor in her field. Her work continues to influence the development of new medicinal compounds, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…